Thermo Fisher Scientific Stock Berne S.E.

Equities

TFS

US8835561023

Advanced Medical Equipment & Technology

Delayed Berne S.E. 12:00:02 2024-04-02 EDT 5-day change 1st Jan Change
514.5 CHF -0.35% Intraday chart for Thermo Fisher Scientific -0.35% +19.58%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 43.01B 39.04B 58.76B Sales 2025 * 46.08B 41.83B 62.96B Capitalization 225B 205B 308B
Net income 2024 * 6.11B 5.55B 8.35B Net income 2025 * 7B 6.36B 9.57B EV / Sales 2024 * 5.8 x
Net Debt 2024 * 23.99B 21.78B 32.78B Net Debt 2025 * 19.18B 17.42B 26.21B EV / Sales 2025 * 5.31 x
P/E ratio 2024 *
37.3 x
P/E ratio 2025 *
31.8 x
Employees -
Yield 2024 *
0.25%
Yield 2025 *
0.28%
Free-Float 86.04%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 56 01-10-31
Director of Finance/CFO 57 01-05-31
Chief Tech/Sci/R&D Officer - 18-12-31
Members of the board TitleAgeSince
Chief Executive Officer 56 01-10-31
Director/Board Member 67 12-03-29
Director/Board Member 62 22-02-28
More insiders
Thermo Fisher Scientific Inc. specializes in the design, manufacturing and marketing of laboratory and scientific equipments. Net sales (including intragroup) break down by family of products as follows: - laboratory equipments (70%). Moreover, the group proposes chemical products (reagents, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.; - diagnostics equipment and products (15.3%); - scientific analysis equipments (14.7%): analyzer (of water, gas, grounds, etc.), mass spectrometers, molecular spectroscopes, microscopes, manometers, samplers, microbiology equipments, reactive agents, etc. Net sales break down by source of income into products sales (78.5%) and services (21.5%). Net sales break down geographically as follows: North America (53%), Europe (25.7%), Asia-Pacific (18.1%) and others (3.2%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
590.7 USD
Average target price
625.5 USD
Spread / Average Target
+5.89%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW